Leukemia & Lymphoma Society Seeks Applications for Translational Research

The Leukemia & Lymphoma Society is the world's largest voluntary health agency dedicated to funding blood cancer research, education, and patient services. Its mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

To advance these goals, the society's Translational Research Program was developed to encourage and provide early support for clinical research in leukemia, lymphoma, and myeloma focused on innovative approaches to treatment, diagnosis, and prevention. The program is designed to support new and innovative research that demonstrates high promise for translating basic biomedical knowledge to clinical application. Projects should be based on molecular, cellular, or integrated systems findings and be conceptually innovative.

Grants are limited to a maximum of $600,000 over three years.

To be eligible, applicants must hold an MD, PhD, or equivalent degree and work in a domestic or foreign nonprofit organizations such as a university, college, hospital, or laboratory.

Letters of Intent must be received no later than September 29, 2017. Upon review selected applicants will be invited to submit a full proposal by November 15, 2017.

For complete program guidelines and application procedures, see the LLS website.

Not the right RFP?

Not the right RFP?

See who will support your mission with Foundation Directory Online.

Foundation Directory Online allows you to search all 100,000 U.S foundations at once.
Target your search by field of interest, type of support, geographic focus, and more.

Find the plan that's right for you